コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 h transactivation of the HIV promoter by the Tat protein.
2 a cell-penetrating peptide derived from the TAT protein.
3 es capable of neutralizing the effect of the Tat protein.
4 those observed for peptides derived from the Tat protein.
5 human immunodeficiency virus type I (HIV-1) Tat protein.
6 oter of HIV-1 that is activated by the HIV-1 Tat protein.
7 n sequence from human immunodeficiency virus TAT protein.
8 similar to those of the ungulate lentiviral Tat protein.
9 s for deleterious mutations elsewhere in the Tat protein.
10 PTD) derived from the human immunodeficiency TAT protein.
11 erase II is strongly stimulated by the viral Tat protein.
12 onal repression by DRB and activation by the Tat protein.
13 human immunodeficiency virus type 1 (HIV-1) Tat protein.
14 n elongation complexes is inhibited by HIV-1 Tat protein.
15 ed cells were treated with exogenously added Tat protein.
16 n in the presence of either DRB or the HIV-1 Tat protein.
17 Vpu also expressed a functional single-exon Tat protein.
18 fection with HIV-1, in part due to the HIV-1 Tat protein.
19 physical interaction between MED14 and HIV-1 Tat protein.
20 annels in the response of microglia to HIV-1 Tat protein.
21 least 1000-fold more toxic than recombinant Tat protein.
22 orescence microscopy of Texas Red-conjugated TAT proteins.
23 for transcriptional activation by lentivirus Tat proteins.
24 o the translocon, FRET was observed for both Tat proteins.
25 g the HIV-1 transactivator of transcription (Tat) protein.
26 e and HIV-1 transactivator of transcription (Tat) protein.
27 dies examined the ability of two variants of Tat protein (1-100 nM), Tat 1-72 and Tat 1-86, to produc
29 s cellular defense, HIV-1 has evolved in its Tat protein a suppressor of RNA silencing (SRS) function
30 he human immunodeficiency virus type 1 (HIV) Tat protein, a potent activator of HIV gene expression,
32 l region of the human immunodeficiency virus Tat protein, a protein transduction domain known to ente
33 demonstrate that highly divergent lentiviral Tat proteins activate transcription from their cognate L
35 wnstream of the MyD88 and TRIF pathways, the Tat protein activated the protein kinase C (PKC) betaII
37 Human immunodeficiency virus, type 1 (HIV-1) Tat protein activates transcription from the HIV-1 long
38 s basal HIV gene expression and that the HIV Tat protein activates transcription independently of the
39 uman immunodeficiency virus, type 1 (HIV-1), Tat protein activates viral gene expression through prom
40 T-tg or C57BL/6J mice; however, induction of Tat protein after the extinction of CPP also produced re
41 by vGPCR was greatly increased by the HIV-1 Tat protein, although Tat alone had little effect on NF-
42 ransduction domain (PTD) embedded in the HIV TAT protein (amino acids 47-57) has been shown to succes
43 study was to determine whether and how HIV-1 Tat protein, an immunosuppressive viral factor, induces
44 PI3K-dependent inhibition required the viral Tat protein and a trans activation response region eleme
45 ar cofactor cyclin T1, which binds the viral Tat protein and activates the RNA polymerase II transcri
47 ble to that of the RNA-binding domain of the Tat protein and inhibited protein binding to the RNA.
48 uction of NO production by recombinant HIV-1 Tat protein and inhibition of RSV-tat-induced NO product
49 anges conformation in response to binding of Tat protein and of a variety of peptidic and small molec
50 e suggest a model where CycT1 interacts with Tat protein and positions the protein complex to make co
52 M) of the human immunodeficiency virus (HIV) Tat protein and TAR RNA is essential for Tat activation
54 mation of a specific complex between the HIV Tat protein and the small RNA element TAR is critical fo
55 cture, termed TAR RNA, in concert with HIV-1 Tat protein and these positive and negative elongation f
56 protein transduction domain (PTD) of the HIV/TAT protein and transduced pancreatic islets ex vivo wit
57 ciates with the human immunodeficiency virus Tat protein and with the transactivation response elemen
58 man immunodeficiency virus 1-transactivator (Tat) protein and linked to the mitochondrial targeting s
59 V replication, with associated production of Tat protein, and C. parvum infection synergistically inc
60 with the human immunodeficiency virus type 1 Tat protein, and Drosophila mof, a gene essential for ma
61 s have documented the neurotoxic property of Tat protein, and Tat has therefore been proposed to cont
62 observed that neuronal cultures treated with Tat protein are protected from Tat-mediated cytotoxicity
63 ysiology of M. smegmatis and homologs of the TAT proteins are also present in the genome of Mycobacte
66 ptide mimic of the RNA-binding domain of BIV Tat protein based on a designed beta-hairpin scaffold.
67 d, however, by immunization with inactivated Tat protein before vaccination with the bicistronic gp12
68 tides from the carboxy terminus of the HIV-1 Tat protein bind to the apical stem-loop region of TAR R
69 The arginine-rich RNA-binding domains of the Tat proteins bind to their cognate transactivation respo
74 NF-kappa B, AP-1, JNK, and apoptosis by HIV-tat protein but has minimal or no role in activation of
79 ch as HIV-1 Transactivator of Transcription (Tat) protein can activate microglia is thus of paramount
82 histiocytic lymphoma U937 cells with the HIV-tat protein causes activation of JNK and AP-1 in a time-
83 piCCT1 has a region of similarity to the HIV Tat protein cell-transduction domain, we tested whether
84 RNA polymerase II, is regulated by the HIV-1 Tat protein, CK2, TFIIB, and the large subunit of TFIIF
85 in vitro biochemical assays with recombinant Tat protein confirmed that TR1 targets two disulfide bon
87 cause HIV-1 Transactivator of Transcription (Tat) protein continues to be present despite antiretrovi
93 exposure of cultures to a deletion mutant of Tat protein devoid of amino acids 31-61 (Tat Delta31-61)
95 Moreover, the CycT1 complex formed by each Tat protein displays a distinct RNA target specificity t
96 pendent on the same cellular cofactor as the Tat proteins encoded by other lentiviruses, is neverthel
99 uorum-sensing and uncover a function for the Tat protein export system in the production of secreted
102 ly proposed a two-step model where the viral Tat protein first preassembles at the promoter with an i
103 The pretreatment of human monocytes with Tat protein for 10 to 30 min suffices to irreversibly en
104 d to the nontoxic transduction domain of the tat protein from human immunodeficiency virus type 1 (ta
105 recently identified inhibitors of the viral Tat protein from the bovine immunodeficiency virus (BIV)
107 ates transactivation by Tat and suggest that Tat proteins function by localizing such a PITALRE-conta
108 Brief exposure (10 min) to each variant of Tat protein (>1 nM) markedly increased levels of intrace
109 athione peroxidase, NK-lysin/granulysin, HIV Tat protein, H(2)O(2), lipid hydroperoxides, vitamin K,
113 human immunodeficiency virus type 1 (HIV-1) Tat protein has been reported to transactivate several c
114 ddition, our results indicate that the alpha-TAT protein has functions that require acetyltransferase
115 findings are particularly important because Tat protein has recently been detected in the brain of H
116 ated that a TAT peptide derived from the HIV TAT protein has the ability to transduce peptides or pro
117 Several HIV-1-derived proteins including the Tat protein have been shown to transcriptionally repress
120 human immunodeficiency virus type 1 (HIV-1) Tat protein (hTat) activates transcription initiated at
123 ndent on the presence of both HAT domain and Tat proteins, implying that Tat influences the transcrip
127 gain a better understanding of the roles of Tat protein in HIV-1 neuropathogenesis, we attempted to
129 nly further highlights the importance of HIV Tat protein in HIV/neuroAIDS, but also presents a new st
130 wn to suppress transcriptional activation by Tat protein in human cells with an IC(50) of approximate
132 ctivation, we explored the role of the HIV-1 Tat protein in inducing the expression of these endogeno
135 R is not required for binding by recombinant Tat protein in vitro, suggesting that the loop region ac
136 L response to autologous virus Env, Gag, and Tat proteins in three patients, and investigated the ext
138 mbinant biologically active HIV-1-associated Tat protein increased FasL expression in the cytoplasm o
139 cryptosporidiosis, we found that recombinant Tat protein increased TLR4 mRNA expression in both uninf
141 itioned media from astrocytes or recombinant Tat protein inhibited NPC proliferation and migration an
143 in the brain, or by injection of recombinant Tat protein into the brain, which may cause secondary st
144 human immunodeficiency virus type 1 (HIV-1) Tat protein is a key pathogenic factor in a variety of a
146 eptide from the Jembrana disease virus (JDV) Tat protein is a structural "chameleon" that binds bovin
147 efore, this study analyzed whether the HIV-1 Tat protein is able to activate these two pathways separ
148 g domain of the Jembrana disease virus (JDV) Tat protein is able to recognize two different TAR RNA s
150 l repeat (LTR) promoter element by the viral Tat protein is an essential step in the HIV-1 life cycle
153 human immunodeficiency virus type 1 (HIV-1) Tat protein is essential for viral replication and stimu
155 that the bovine immunodeficiency virus (BIV) Tat protein is fully able to bind to BIV TAR both in viv
156 mmunodeficiency virus (HIV) infection, HIV-1 Tat protein is known to synergize with psychostimulant d
157 protein Puralpha and the HIV type 1 (HIV-1) Tat protein is mediated by specific ribonucleic acids.
160 n of the bovine immunodeficiency virus (BIV) Tat protein is shown to bind specifically to its target
164 we showed that neurotoxic factors other than Tat protein itself were present in the supernatant of Ta
165 in a Jurkat cell line stably expressing the Tat protein (Jurkat-Tat) or in Jurkat cells treated with
168 ion with HIV-1 or stimulation with the HIV-1 Tat protein leads to the activation of K111 proviruses.
169 TLR4 pathway with rapid kinetics, the HIV-1 Tat protein leads to the engagement of both the MyD88 an
170 TLR4 pathway with rapid kinetics, the HIV-1 Tat protein leads to the engagement of both the MyD88 an
172 Human immunodeficiency virus-1 tat (HIV-tat) protein, like other proinflammatory cytokines (such
173 hat the HIV transactivator of transcription (Tat) protein manipulates the intrinsic toggling of HIV's
176 y virus type 1 (HIV-1) potent transactivator Tat protein mediates pleiotropic effects on various cell
177 To characterize the mechanism by which HIV-1 Tat protein modulates human brain microvascular endothel
178 ned whether exposure of susceptible cells to Tat protein of HIV could result in the production of sel
182 ation to define the interactions between the Tat proteins of Escherichia coli at molecular-level reso
184 Here we investigated the effects of the Tat protein on enteric neuronal excitability, proinflamm
185 the KS-promoting factor TNF-alpha, the HIV-1 Tat protein, or the human herpesvirus 8 protein ORF74, w
186 The transacting activator of transduction (TAT) protein plays a key role in the progression of AIDS
187 e 1 (HIV-1) transactivator of transcription (Tat) protein possesses a unique membrane-transduction pr
189 ady-state RNA levels, and with intracellular Tat protein production, suggesting that antisense transc
190 nding to the same site as arginine 52 of the Tat protein, rather than to the neomycin binding site.
193 human immunodeficiency virus type 1 (HIV-1) Tat protein recruits positive transcription elongation f
194 human immunodeficiency virus type-1 (HIV-1) Tat protein regulates transcription by stimulating RNA p
198 ed with a variant TAR able to bind all three Tat proteins replicate efficiently with any of the prote
199 LTR) promoter element by the essential viral Tat protein requires recruitment of positive transcripti
200 demonstrated that exposure of HUVECs to HIV Tat protein resulted in induced expression of cell adhes
201 domain from the human immunodeficiency virus TAT protein, results in delivery of the biologically act
202 position 31, found in >90% of HIV-1 clade C Tat proteins, results in a marked decrease in IL-10 prod
204 component of the twin-arginine translocase (Tat) protein secretion pathway and likely forms a secret
206 found that treatment of DCs with whole HIV-1 Tat protein significantly upregulated the level of expre
213 cein-labeled TAR RNA and a rhodamine-labeled Tat protein synthesized through solid-phase chemistry.
214 uction was achievable, as minimum amounts of Tat protein, synthesized following application of a shor
215 n domain of the human immunodeficiency virus TAT protein (Tat), an Angiopep peptide (Ang-2), and the
216 Here, we report that ACs treated with HIV-1 Tat protein (Tat-ACs) have a decreased ability to organi
218 treatment with a CRMP2 peptide fused to HIV TAT protein (TAT-CBD3) blocked neuronal death following
219 udy the interaction between PTD of the HIV-1 Tat protein (TAT-PTD; residues 47-60 of Tat, fluorescent
221 to the HIV transactivator of transcription (TAT) protein (TAT-CBD3) decreased neuropeptide release f
222 ed to the protein transduction domain of HIV-TAT protein (TATFLAGVHL-peptide) to facilitate entry int
223 An 11-residue basic domain of the HIV-1 tat protein, termed the tat transduction domain (TTD), h
224 element is regulated by the essential viral Tat protein that binds to the viral TAR RNA target and r
225 netrating peptide (CPP) conjugate of the HIV TAT protein that is fused to an aminoterminal sequence o
226 immunodeficiency virus (SIVmnd), also encode Tat proteins that activate transcription via RNA targets
227 ty is seen in viral replication assays using Tat proteins that rely on CycT1 for TAR binding but are
228 upporting HIV-1 transactivation by the viral Tat protein, the AFF4-SEC is more important for HSP70 in
229 ed by the human immunodeficiency virus (HIV) Tat protein to activate elongation of the integrated pro
233 in concert with these factors and the HIV-1 Tat protein to ensure that viral transcription is induce
235 conjugation of peptides derived from the HIV TAT protein to membrane-impermeant molecules has gained
238 continues to synergize normally with the HIV Tat protein to transactivate the HIV long terminal repea
239 at is responsible for the inability of these Tat proteins to produce high IL-10 levels in monocytes d
240 report that binding of HIV-1 transactivator (Tat) protein to low-density lipoprotein receptor-related
242 th versions of these peptides containing HIV-Tat protein transduction and mammalian mitochondrial tar
244 or-associated Ag (OVA) that contains the HIV TAT protein transduction domain (PTD) was readily engine
245 r uptake of the human immunodeficiency virus TAT protein transduction domain (PTD), or cell-penetrati
246 ass IA PI3K adaptor subunit, fused to an HIV-TAT protein transduction domain (TAT-Deltap85) concentra
249 d recombinant fusion proteins containing the TAT protein transduction domain and either wild-type Sur
250 ptide was redesigned to TSB2 that includes a TAT protein transduction domain and shortened to 14 aa.
251 een fluorescent protein or dnRas lacking the TAT protein transduction domain did not block airway inf
256 a physiological role for nuclear RACK1, the Tat protein transduction system was used to transduce RA
258 we used the transactivator of transcription (TAT) protein transduction domain to deliver human FXN pr
259 e effect of transactivator of transcription (TAT) protein transduction of the apoptosis repressor wit
263 omponents of the thylakoid deltapH-dependent/Tat protein transport machinery was analyzed in vitro.
264 te the mechanism and energetics of bacterial Tat protein transport, we developed an efficient in vitr
265 protein (GFP)-tagged constructs to study the Tat protein transporter and Rieske Tat substrates in Syn
268 ophobic domain may play an important role in Tat protein uptake and be useful for intracellular deliv
273 Here, we demonstrate that the Cv-pdg-NLS-TAT protein was delivered to repair-proficient keratinoc
275 n domain of the human immunodeficiency virus TAT protein, were tested in in vitro and in vivo experim
276 ion of human immunodeficiency virus requires Tat protein which activates elongation of RNA polymerase
279 opolysaccharide (LPS) and the neurotoxic HIV Tat protein, which cause dopamine neuronal toxicity afte
280 utlined various strategies for detecting the Tat protein, which helps transcribe the virus and enhanc
281 Replication of HIV-1 requires the viral Tat protein, which increases the extent of transcription
282 cy virus (HIV)-1 genes is activated by HIV-1 Tat protein, which induces phosphorylation of the C-term
283 This is mediated in part through the HIV-1 Tat protein, which is secreted by the infected cells and
284 by the human immunodeficiency virus, type 1 Tat protein, which is secreted by virally infected cells
287 ide (Abeta1-6A2V), linked to the HIV-related TAT protein, which is widely used for brain delivery and
289 HIV-1 transcription is activated by HIV-1 Tat protein, which recruits cyclin-dependent kinase 9 (C
290 V-1) transcription is regulated by the viral Tat protein, which relieves a block to elongation by rec
291 human immunodeficiency virus type 1 (HIV-1) Tat protein, which was able to restore the 7SK-binding a
292 V-1) replication requires the interaction of Tat protein with the human cyclinT1 (hCyclinT1) subunit
293 1 (HIV-1) requires specific interactions of Tat protein with the trans -activation responsive region
294 1 (HIV-1) requires specific interactions of Tat protein with the trans-activation responsive region
295 expression that requires the interaction of Tat protein with the trans-activation responsive region
296 expression that requires the interaction of Tat protein with the trans-activation responsive region
297 1 (HIV-1) requires specific interactions of Tat protein with the trans-activation responsive region
298 ciency virus (HIV) tat and boosting with the Tat protein would elicit protection against SHIV(89.6P).
299 to membrane translocation signals from HIV-1 tat protein (YGRKKRRQRRRPP-LRK(5)H, DT-2) or Drosophila
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。